The American College of Cardiology (ACC) 2022 Scientific Session was a hybrid event which took place from April 2 to 4, 2022, in Washington, USA and online. Here is the curated list of the top highlights of the ACC 2022 sessions. SODIUM-HF trial1: This international trial (NCT02012179) followed 806 adult patients with chronic heart failure (CHF) receiving optimally … [Read more...] about Top Highlights of ACC 2022
Imaging
Value of real-world DOAC data on atrial fibrillation treatment
Following the approval of direct oral anticoagulants (DOACs) a number of real-world studies were initiated to look at their impact on atrial fibrillation (AF) patients seen in daily practice. Unlike randomized controlled trials, real-world studies do not have strict exclusion criteria and look include many AF patients with various comorbidities. However, there are fundamental … [Read more...] about Value of real-world DOAC data on atrial fibrillation treatment
Top Cardiology Conferences 2022
Looking ahead here is our curated list (in order, by date) of the top cardiology conferences planned for 2022. 19th International Conference on Pediatrics and Pediatric Cardiology May 18-19, 2022 Location: Amsterdam, Netherlands & Online The main focus and theme for the Pediatric Cardiology 2022 conference is “Emerging interventions in Pediatric … [Read more...] about Top Cardiology Conferences 2022
Lowering target systolic blood pressure may decrease cardiovascular events
International Society of Hypertension global hypertension guidelines1 and European Society of Cardiology guidelines2 both recommend that hypertension be diagnosed if a patient’s systolic blood pressure is ≥140 mmHg and/or their diastolic blood pressure is ≥90 mmHg. Researchers wondered if pharmaceutical intervention at a lower systolic blood pressure could further reduce the … [Read more...] about Lowering target systolic blood pressure may decrease cardiovascular events
Fractional flow reserve vs angiography-guided revascularization
Fractional flow reserve (FFR) guided revascularization did not demonstrate any benefit over angiography guided revascularization in the FLOWER-MI trial. In patients with ST-elevated myocardial infarction (STEMI) and multi-vessel disease, complete vascularization is associated with better clinical outcomes than vascularization of only the culprit lesion. Current … [Read more...] about Fractional flow reserve vs angiography-guided revascularization